January - March 2012
March 29, 2012
Takeda Pharmaceutical Company Limited
Osaka, Japan, March 29, 2012—Takeda Pharmaceutical Company Limited (“Takeda”) announced today that its Corporate Strategy & Planning Department and Finance & Accounting Department will jointly be reorganized to form two new departments which are Corporate Strategy Dept. and Corporate Finance & Controlling Dept., effective April 1st, 2012, with its newly announced heads reporting to the President & CEO directly. This reorganization is intended to ensure steady growth as a global pharmaceutical company by reinforcing the Company’s corporate strategy function with a focus on the mid and long-term perspective, and enhancing corporate management and cash flow management functions.
Takeda is currently advancing its initiatives for “Transformation into a New Takeda” to ensure sustainable growth, and such initiatives are guided by the company’s vision of achieving sustainable “Growth through Innovation and Culture”. As a part of that transformation, Takeda made a remarkable step forward last year with the acquisition of Nycomed which has strong business infrastructures in Europe and emerging markets. As a result, now Takeda’s business expands in more than 70 countries. This global expansion has increased the need for reviewing Takeda’s global organization structure with the goal of enhanced global governance. The reorganization announced today meets such a need.
The detailed description of two new departments’ functions is as follows:
The Corporate Strategy Department will contribute to improving the quality of decision-making by collecting and analyzing information about global business environments and industry trends, and proposing business strategies and direction from the mid to long-term global perspective. In addition, the department will provide proposals of best practices in response to business environment changes, and support the formulation of corporate strategy and business strategies of operating divisions of the Company.
As the global controller function of the Takeda group, the Corporate Finance & Controlling Department is responsible for the formulation and tracking of Mid-Range and Annual plans in collaboration with Takeda’s global functions. In addition, the department will have responsibility for business management including administrative accounting and the settlement of accounts as a report of the Company’s financial performance to stakeholders, taxation, and finance functions as part of cash-flow management.
These two new departments will be the primary global governance functions at headquarters for the Takeda group. With the goal of transparency of corporate management for various stakeholders, the corporate headquarters will work in a highly collaborative manner with Takeda’s global and international functions to ensure long-term, sustainable growth and the maximization of the corporate value.
Takeda is committed to bringing innovative medicines to patients and the healthcare providers who treat them all over the world, with the continued dedication to “Transformation into a New Takeda.”
# # #
Located in Osaka, Japan, Takeda is a research-based global company with its main focus on pharmaceuticals. As the largest pharmaceutical company in Japan and one of the global leaders of the industry, Takeda is committed to striving toward better health for individuals and progress in medicine by developing superior pharmaceutical products. Additional information about Takeda is available through its corporate website, www.takeda.com.
# # #